References
- D. Brodie, P. Cook, B. Bauer, and G. Dagle.(1970). Indomethacin‐induced intestinal lesions in rat Toxicol. Appl. Pharmacol 17:615–624.
- W. Chiou, and S. Riegelman.(1971). Applications of solid dispersion systems J. Pharm. Sci 60:1281–1302.
- V. Cioli, V. Putzolus Rossi, P. Scorza‐Barcellona, and C. Corradino.(1979). The role of direct tissue contact in the production of gastrointestinal ulcers by anti‐inflammatory drugs in rats Appl. Pharmacol 50:283–289.
- V. Cioli, S. Putzolu, V. Rossi, and C. Corradino.(1980). A toxicological and pharmacological study of ibuprofen guaiacol ester (AF 2259) in the rat Toxicol. Appl. Pharmacol 54:332–339.
- P. Dalal, and M. Narurkar.(1991). In vitro and in vivo evaluation of sustained release suspensions of ibuprofen Int. J. Pharm 73:157–162.
- W. Fang, A. Broughton, and E. Jacobson.(1977). Indomethacin induced inflammation Dig. Dis 22:749–760.
- G. Glavin, and D. Sitar.(1986). The effects of sulindac and its metabolites on stress‐induced gastric ulcers in rats Toxicol. Appl. Pharmacol 83:386–389.
- J. Hilton, and M. Summers.(1986). The effect of polyvinylpyrrolidones on the intestinal ulceration caused by indomethacin Int. J. Pharm 32:13–19.
- A. Karnachi, R. Dehon, and M. Khan.(1995a). Compression of indomethacin coprecipitates with polymer mixtures: Effect of preparation methodology Drug. Dev. Ind. Pharm 21:1473–1483.
- A. Karnachi, and M. Khan.(1996). Box‐Behnken design for the optimization of formulation variables of indomethacin co‐precipitates with polymer mixtures Int. J. Pharm 131:9–17.
- M. Khan, A. Karnachi, S. Singh, S. Sastry, S. Kislalioglu, and S. Bolton.(1995). Controlled release coprecipitates: formulation considerations J. Cont. Rel 37:131–141.
- S. Leyck, N. Dereu, E. Etschenberg, M. Ghyczy, E. Graf, J. Winkelmann, and M. Parnham.(1985). Improvement of the gastric tolerance of non‐steroidal anti‐inflammatory drugs by polyene phosphatidylcholine Eur. J. Pharmacol 117:35–42.
- L. Lichtenberger, L. Graziani, E. Dial, B. Butler, and A. Hills.(1983). Role of surface‐active phospholipids in gastric cytoprotection Science 219:1327–1329.
- J. Nakamura, M. Katayama, K. Nishida, and H. Sasaki.(1992). An assessment of indomethacin‐induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine Chem. Pharm. Bull 40:1261–1265.
- K. Rainsford.(1989). Mechanisms of gastrointestinal toxicity of non‐steroidal anti‐inflammatory drugs Scand. J. Gastroent 24:9–16.
- D. Shriver, C. White, A. Sandor, and M. Rosenthale.(1975). A profile of rat gastrointestinal toxicity of drugs used to treat inflammatory diseases Toxicol. Appl. Pharmacol 32:73–83.
- E. Sohengen, E. Godin‐Ostro, F. Fielder, R. Ginsberg, M. Slusher, and A. Weiner.(1988). Encapsulation of indomethacin liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats Arthritis and Rheumatism 31:414–422.
- A. Somogi, K. Kovacs, and H. Selye.(1969). Jejunal ulcers produced by indomethacin J. Pharm. Pharmacol 21:122–123.
- R. Swarm, S. Ashley, D. Soybel, B. Ordway, and L. Cheung.(1986). Protective effect of exogenous phospholipid on aspirin induced gastric mucosal injury Am. J. Surg 153:48–53.
- I. Szlenyi, and H. Engler.(1986). Cytoprotective role of gastric surfactant in the ethanol‐produced gastric mucosal injury of the rat Pharmacology 33:199–205.
- V. Tammara, M. Narurkar, M. Crider, and M. Khan.(1993). Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen Pharm. Res 10:1191–1199.
- B. Whittle, and J. Vane.(1984). A biochemical basis for the gastrointestinal toxicity of non‐steroid anti‐rheumatoid drugs Arch. Tox 7:315–322.